AdvanSource Biomaterials Corporation Stock Price and Value Analysis

Should you buy AdvanSource Biomaterials Corporation stock? (Other OTC:ASNB). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the ASNB Numbers

ASNB Price
(AdvanSource Biomaterials Corporation stock price per share)
$0.02
[?] PE Ratio versus Sector 99% lower than other Healthcare stocks
[?] PE Ratio versus Industry 99% lower than other Medical Instruments & Supplies stocks
[?] Free Cash Flow Jitter 50%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 19,919 shares shorted. With 25,007,111 shares available for purchase and an average trading volume over the past 10 trading days of 34,283, it would take at least 0.581 days for all of the short holders to cover their shorts.

Is AdvanSource Biomaterials Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy AdvanSource Biomaterials Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ASNB Stock?

Does AdvanSource Biomaterials Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.